Chat with Filing

Ask questions about this document
Please log in or register to use the chat feature. Please register first.
POS - Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 17 April 2025

Company: Covivio Date: 2025-04-17 Language: English Register to download
Loading document preview...
Document Preview Not Available

The file type (.pdf) cannot be displayed directly here.
Open Original File
Error loading document preview. Please try the 'Open Original File' link.
You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:
Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon
Paris, 17th April 2025

**Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders' Meeting held on 17 April 2025**

# **OVERVIEW OF THE MAIN FEATURES OF THE SHARE BUY-BACK PROGRAM**

| Issuer                                                                | Covivio ("Covivio" or the "Company")                                                                                                                                                                                     |
|-----------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Share listing                                                         | Euronext Paris - Compartment A                                                                                                                                                                                           |
| Shares concerned                                                      | Covivio Shares (ISIN Code: FR0000064578)                                                                                                                                                                                 |
| Authorization of the transaction                                      | Combined Ordinary and Extraordinary Shareholders' Meeting of 17 April 2025                                                                                                                                               |
| Decision to implement                                                 | Board of Directors' decision of 16 April 2025, subject to the approval of the<br>eighteenth resolution by the Ordinary and Extraordinary General Meeting of<br>17 April 2025                                             |
| Maximum amount of funds<br>allocated to the share buy-back<br>program | €500,000,000                                                                                                                                                                                                             |
| Maximum purchase price per share                                      | €85 (excluding acquisition costs)                                                                                                                                                                                        |
| Main objectives of the share buy<br>back program                      | Implementation of a liquidity contract entered into with an investment services<br>-<br>provider under the conditions and in accordance with the procedures provided<br>by regulations and established market practices; |
|                                                                       | Allocation to executive corporate officers or employees of the Company<br>-<br>and/or companies belonging to its group;                                                                                                  |
|                                                                       | Delivery of shares upon exercise of rights attached to securities giving the<br>-<br>right to the allocation of shares;                                                                                                  |
|                                                                       | Holding and payment or exchange in connection with possible external<br>-<br>growth, merger, demerger or contribution transactions;                                                                                      |
|                                                                       | Cancellation of shares;<br>-                                                                                                                                                                                             |
|                                                                       | -<br>Use in connection with any other practice that may be authorized by law or<br>the Autorité des marchés financiers or any other purpose that may be<br>authorized by applicable law or regulation.                   |
| Duration of the program                                               | Eighteen (18) months starting from the Combined Ordinary and Extraordinary<br>Shareholders' Meeting, i.e. until 16 October 2026                                                                                          |

Pursuant to Article 241-2 of the *Règlement général de l'Autorité des marchés financiers* (AMF*)*, the purpose of this document is to describe the aims and terms of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders' Meeting of Covivio held on 17 April 2025.

## **INFORMATION ON THE SHARE BUY-BACK PROGRAM**

#### **1. AIMS OF THE SHARE BUY-BACK PROGRAM AND USE OF THE SHARES REPURCHASED**

The aims of the share buy-back program authorized by the eighteenth resolution approved by the Combined Ordinary and Extraordinary Shareholders' Meeting of 17 April 2025 are the following:

- to allocate shares to executive corporate officers or employees of the Company and/or of companies belonging to its group, in accordance with the terms and conditions set out in the laws and regulations applicable to (i) the sharing in the benefits due to the Company's growth, (ii) the stock option scheme provided for by Articles L. 225-177 et seq. of the French Commercial Code and L. 22-10-56 of the French Commercial Code, (iii) the scheme for the allocation of free shares as provided for in Articles L. 225-197-1 et seq. of the French Commercial Code and L. 22-10-59 and L. 22-10-60 of the French Commercial Code and (iv) any employee savings plan, as well as to undertake any hedging transaction relating to these transactions, under the conditions stipulated by the market authorities and at such times as the Board of Directors or the individual acting on behalf of the Board of Directors deems suitable;
- to remit the shares during the exercise of rights attached to securities giving the right, immediately or in the future, through redemption, conversion, exchange, presentation of a warrant or any other manner, to the allocation of Company shares, as well as to undertake any hedging transaction in relation to the issuance of such securities, under the conditions stipulated by the market authorities and at such times as the Board of Directors or the individual acting on behalf of the Board of Directors deems suitable;
- to hold the shares and remit them later as payment or in exchange in the context of potential transactions for external growth, merger, split or contribution;
- to cancel all or part of the shares through a reduction in the share capital (specifically in order to optimise cash management, return on equity or earnings per share), subject to twentieth resolution of the Combined Ordinary and Extraordinary Shareholders' Meeting of 17 April 2025;
- to facilitate the liquidity of transactions and consistency in the trading of the Company's shares or to prevent price swings not justified by market trends within the context of a liquidity agreement entered into with an investment services provider operating in complete independence, under the terms and conditions set by regulation and established market practices and in accordance with a code of ethics recognised by the *Autorité des Marchés Financiers*;
- and also with a view to any other practice that could be recognised by the law or the *Autorité des Marchés Financiers* or any other purpose to be authorised by the law or regulations in effect in future. In such a case, the Company would inform its shareholders by sending out a notice.

In the context of the achievement of the fifth aim referred to above, in order to avoid excessive volatility of the share price, Covivio entrusted Exane (investment services provider), as of 11 July 2005, with the implementation of a liquidity contract.

A new liquidity contract was entered into with Exane on 10 January 2019 in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse, Commission Delegated Regulation (EU) 2016/908 of 26 February 2016, which was updated with effect on 1st July 2021 following AMF Decision No 2021-01 of 22 June 2021 on renewal of establishment of liquidity contracts on capital securities as an accepted market practice.

Under the terms of the agreement to transfer the liquidity contract signed on 5 September 2023 between Exane, BNP Paribas Financial Markets (formerly BNP Paribas Arbitrage) and Covivio, the liquidity contract was transferred from 23 October 2023 to BNP Paribas Financial Markets.

It is recalled that pursuant to the provisions of the liquidity contract transferred to BNP Paribas Financial Markets:

- its execution is suspended under the conditions set out in article 5 of the AMF Decision n° 2021-01 of 22 June 2021 and, at the Company's request for a period of time the Company defines;
- the liquidity contract may be terminated at any time, without notice by the Company, and with a one month notice by BNP Paribas Financial Markets, in the term of termination of the liquidity account provided for under the liquidity contract.

Subject to the approval of the twentieth resolution by the General Meeting of 17 April 2025 (the "**Condition Precedent**"), the Board of Directors decided on 16 April 2025 to implement a new share buy-back program, notably through the extension of the existing liquidity contract with BNP Paribas Financial Markets, under the same conditions and on the basis of a maximum purchase price of €85 per share (excluding acquisitions costs). Pursuant to decisions dated 17 April 2025, the Chief Executive Officer acknowledged that the Condition Precedent is completed and confirmed, if required, the implementation of the share buy-back program, under the terms and condition determined by the Board of Directors.

For the continuation of this contract, scheduled from the implementation of this program, Covivio kept the resources allocated to the liquidity account, being specified that on the date of 17 April 2025, the following resources were allocated to the liquidity account:

- 91,858 Covivio shares,
- €5,090,773.

In with the context of the implementation of this program, the maximum amount of funds allocated to the share buy-back program amounts to €500,000,000.

## **2. NUMBER OF SHARES HELD BY COVIVIO – BREAKDOWN OF THE SHARES HELD PER AIM**

Before 17 April 2025, a share buy-back program was authorized by the Combined Ordinary and Extraordinary Shareholders' Meeting of Covivio held on 17 April 2024, and which terms and conditions were described in the overview of the said program made public on 17 April 2024.

As of 17 April 2025, Covivio holds as of the date of this overview:

- 91,858 shares pursuant to the liquidity contract; and
- 781,460 shares assigned to cover employee stock ownership as part of (i) plans of free allocation of Company's shares to Covivio's employees and/or executive corporate officers and/or companies belonging to its group and (ii) investment of the profit-sharing (plus the related contribution) by employees of Covivio's UES in shares of the Company.

The Company did not use any derivatives under this previous share buy-back program.

## **3. LEGAL FRAMEWORK**

This program is made in accordance with the provisions of:

- Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR);
- Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buy-pack programmes and stabilisation measures;
- Articles L. 225-210 et seq. of the French Commercial Code;
- Articles L. 22-10-62 et seq. of the French Commercial Code;
- Article L 451-3 of the French Monetary and Financial Code;
- Articles 241-1 to 241-7 of the general regulation of the AMF;
- AMF Instruction No 2017-03 of 2 February 2017 on the methods for notifying transactions carried out as part of dealings by listed issuers in their own shares and stabilisation measures;
- AMF Position-recommendation No 2017-04 of 2 February 2017, updated on 29 April 2021, on the guide relating to trading by issuers in their own shares and stabilisation measures;
- AMF Decision No 2021-01 of 22 June 2021 on renewal of establishment liquidity contracts on capital securities as an accepted market practice and any other provisions referred to therein.

This buy-back program was authorized by the eighteenth resolution approved by the Combined Ordinary and Extraordinary Shareholders' Meeting of 17 April 2025.

## **4. TERMS**

## **4.1. Characteristics of the shares concerned by the share buy-back program**

Covivio ordinary shares (ISIN Code: FR0000064578), all of the same category, bearer or registered, listed on Euronext Paris – Compartment A.

# **4.2. Maximum portion of the share capital that may be acquired and maximum amount payable by Covivio**

Pursuant to the resolution approved by the Combined Ordinary and Extraordinary Shareholders' Meeting of Covivio held on 17 April 2025, the number of shares that the Company is authorized to purchase shall not exceed 10% of the shares composing the Company's share capital (at any given time, this percentage shall apply to the share capital taking into account transactions affecting it after the Shareholders' General Meeting), i.e. for information purposes 11,162,346 shares on the date of this overview.

It is specified that in the event of a purchase under the liquidity contract, the number of shares considered for the calculation of the limit of 10% of the above-mentioned amount of share capital shall correspond to the number of shares purchased, less the number of shares resold during the term of this authorization.

However, the number of shares purchased in view of conserving them and handing them over subsequently for payment or exchange within the context of a merger, demerger or contribution, shall not exceed 5% of the Company's share capital.

The maximum purchase price per share is set at €85 (excluding purchase costs).

On the basis of the number of shares composing the share capital on the date of this overview (111,623,468 shares) and taking into account 873,318 treasury shares, the maximum number of shares that is likely to be purchased would amount to 10,289,028 shares. However, it is recalled that pursuant to the eighteenth resolution approved by the Combined Ordinary and Extraordinary Shareholders' Meeting of Covivio held on 17 April 2025, the maximum amount of funds allocated to the share buy-back program is one hundred and five hundred million euros (€500,000,000).

# **4.3. Terms and conditions of the repurchase**

The acquisition, sale, exchange or transfer of shares may be carried out at any time, except as from the filing by a third party of a tender offer on the Company's shares, until the end of the offer period, and by any means, including by trading on a regulated market or a multilateral trading facility, with systematic internalisers or over the counter particularly including through the acquisition or sale of blocks of shares (on or off the market), takeover or public exchange offering, as well as through the use of financial instruments, specifically derivative financial instruments traded on a regulated or over-the-counter market, such as calls or puts options or any combinations thereof, or by recourse to warrants, either directly or indirectly through an investment service provider, under the conditions authorised by the competent market authorities and at such times as the Company's Board of Directors deems fit. The maximum portion of the share capital acquired or transferred in the form of blocks of shares may comprise up to the entire program.

In the event of a change in the par value of the share, a capital increase by incorporation of reserves, a free allocation of shares, a split or regrouping of shares, a distribution of reserves or of any other assets, a capital depreciation or any other transaction relating to the shareholders' equity, the maximum purchase price will be adjusted by decision of the Board of Directors to take into account the impact of these transactions on the value of the share.

## **4.4. Duration of the share buy-back program and calendar**

This share buy-back program shall be implemented within a limited period of eighteen (18) months starting from the date of the Combined Ordinary and Extraordinary Shareholders' Meeting, i.e. until 16 October 2026 at the latest.

## **4.5. Financing of the share buy-back program**

The purchases will be financed in part by Covivio's own resources or, where applicable, by means of debts for additional needs that exceed its self-financing.

#### **5. UNIVERSAL REGISTRATION DOCUMENT**

The universal registration document of Covivio for the year ended 31 December 2024 was filed within the *Autorité des marchés financiers* on 19 March 2025 under number D.25-0117.

![](_page_5_Picture_4.jpeg)

**Press Relations** Géraldine Lemoine Tel: + 33 (0)1 58 97 51 00 [geraldine.lemoine@covivio.fr](mailto:geraldine.lemoine@covivio.fr)

Louise-Marie Guinet Tel: + 33 (0)1 43 26 73 56 [covivio@wellcom.fr](mailto:covivio@wellcom.fr)

**Investor Relations** Vladimir Minot Tel: + 33 (0)1 58 97 51 94 [vladimir.minot@covivio.fr](mailto:vladimir.minot@covivio.fr)

![](_page_5_Picture_8.jpeg)

Thanks to its partnering history, its real estate expertise and its European culture, Covivio is inventing today's user experience and designing tomorrow's city.

A preferred real estate player at the European level, Covivio is close to its end users, capturing their aspirations, combining work, travel, living, and co-inventing vibrant spaces.

A benchmark in the European real estate market with €23.1 bn in assets, Covivio offers support to companies, hotel brands and territories in their pursuit for attractiveness, transformation and responsible performance.

Build sustainable relationships and well-being, is the Covivio's Purpose who expresses its role as a responsible real estate operator to all its stakeholders: customers, shareholders and financial partners, internal teams, local authorities but also to future generations and the planet. Furthermore, its living, dynamic approach opens up exciting project and career prospects for its teams.

Covivio's shares are listed in the Euronext Paris A compartment (FR0000064578 - COV), are admitted to trading on the SRD, and are included in the composition of the MSCI, SBF 120, Euronext IEIF "SIIC France" and CAC Mid100 indices, in the "EPRA" and "GPR 250" benchmark European real estate indices, and in the ESG FTSE4 Good, CAC SBT 1.5°C, DJSI World & Europe, Euronext Vigeo (World 120, Eurozone 120, Europe 120 and France 20), Euronext® CDP Environment France EW, ISS ESG, Ethibel and Gaïa ethical indices and also holds the following awards and ratings: CDP (A-), GRESB (88/100, 5-Star, 100% public disclosure), ISS-ESG (B-) and MSCI (AAA).

#### **Notations solicited:**

Financial part: BBB+ / Stable outlook by Standard and Poor's